Our results provide a novel target, CCAT2, in the mechanism of action of vitamin D. The data strengthen the support of vitamin D as a key nutraceutical to prevent ovarian cancer invasion and metastasis. This evidence concerns the gene CCAT2 and ovarian carcinoma.